Anytime you microdose you run the risk of not putting enough of a drug in your system to get its benefits, but experimenting with lower doses may also come with upsides, including fewer side effects
Glucagon-like peptide-1 (GLP-1), as one of the important targets for the treatment of type 2 diabetes mellitus (T2DM), has obvious therapeutic effect, short half-life and easy to be cleared
Comparing Cagrilintide to Other Weight Management Therapies While several therapies exist for the treatment of obesity, cagrilintide stands out due to its unique dual receptor agonism
The makers of Wegovy and Zepbound have lowered the price for people paying out of pocket for the popular GLP-1 weight loss drugs
This GRAS designation does not imply FDA approval for therapeutic, drug, or compounded use , and it is sometimes misrepresented in marketing copy
Most people taking GLP-1 medications experience mild to moderate side effects, with nausea, vomiting, and gastrointestinal discomfort being the most common